Free software that measures brain tumors on scans still needs testing
Original title: Validation of open-source deep learning segmentation tools for automated glioma volumetry: a narrative review of Dice scores, workflow efficiency, and clinical RANO 2.0 implementation.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a review of software tools, not a new treatment tested in people.
The short version
Free tools can outline brain tumors on scans, but they are not ready for clinics.
What was studied. Researchers reviewed thirteen free, open-source software tools. The tools read MRI scans and outline gliomas so the tumor can be measured.
What they found. The tools matched expert outlines with scores from 0.73 to 0.92. But in 85% of the treatment response studies, there was a risk that patients were picked in a biased way. As of November 2024, no tool had been formally tested against RANO 2.0, the current rules for measuring tumor response.
What this means, and what it doesn't
What it could mean: Someday these tools could help doctors measure tumors in a more standard way. That could make it easier to tell if a treatment is working. Today, your care team still measures your scans the way they do now.
What it doesn't mean: This is not a new treatment, and it is not a cure. It is a review of software, not a study of people getting care. The authors say no tool has been formally checked against the current rules yet. Nothing here changes the care you get today.
Source: PubMed, July 29, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.